Frontiers | New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Biological characteristics of IL-6 and related intestinal diseases
Frontiers | Serum Biomarkers for Inflammatory Bowel Disease
Schematic model of IL-6/STAT3 pathway in inflammatory bowel disease.... | Download Scientific Diagram
Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study | PLOS ONE
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development | The Journal of Immunology
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target: Molecular Therapy
Il‐6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance - Mudter - 2007 - Inflammatory Bowel Diseases - Wiley Online Library
Immunopathogenesis of IBD: current state of the art | Nature Reviews Gastroenterology & Hepatology
STAT3 pathway and IL6/STAT3/S1PR1 amplification loop in IBD-CRC. | Download Scientific Diagram
Biological characteristics of IL-6 and related intestinal diseases
JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products | HTML
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development
Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases | SpringerLink
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis - ScienceDirect
Gastrointestinal Disorders | Free Full-Text | CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease | HTML
Serum IL-6 and TNF-α levels of mice with DSS-induced colitis treated... | Download Scientific Diagram
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis - ScienceDirect
Frontiers | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity | Science Immunology
Translating IL-6 biology into effective treatments | Nature Reviews Rheumatology
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease - ScienceDirect
Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation - ScienceDirect
Frontiers | IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology
Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway | BMC Complementary Medicine and Therapies | Full Text
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology | Nature Reviews Gastroenterology & Hepatology
I-Mab's IL-6 drug hits goal in ulcerative colitis phase 2 | Fierce Biotech
